勘误：同步放化疗联合免疫检查点抑制剂治疗局部晚期宫颈癌的疗效和安全性：一项系统评价与荟萃分析
Corrigendum: Efficacy and safety of chemoradiotherapy plus immune checkpoint inhibitors for the treatment of locally advanced cervical cancer: a systematic review and meta-analysis.
作者信息
Zhao Zhihong, Ruan Jian, Fang Minjie, Liu Jingwen, Liao Guixiang
机构信息
Department of Radiation Oncology, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, Shenzhen, China.
出版信息
Front Immunol. 2024 Nov 20;15:1524791. doi: 10.3389/fimmu.2024.1524791. eCollection 2024.
Abstract
[This corrects the article DOI: 10.3389/fimmu.2024.1459693.].
摘要
[本文更正了文章DOI：10.3389/fimmu.2024.1459693。]
相似文献
1
Corrigendum: Efficacy and safety of chemoradiotherapy plus immune checkpoint inhibitors for the treatment of locally advanced cervical cancer: a systematic review and meta-analysis.勘误：同步放化疗联合免疫检查点抑制剂治疗局部晚期宫颈癌的疗效和安全性：一项系统评价与荟萃分析
Front Immunol. 2024 Nov 20;15:1524791. doi: 10.3389/fimmu.2024.1524791. eCollection 2024.
2
Efficacy and safety of chemoradiotherapy plus immune checkpoint inhibitors for the treatment of locally advanced cervical cancer: a systematic review and meta-analysis.放化疗联合免疫检查点抑制剂治疗局部晚期宫颈癌的疗效和安全性：系统评价和荟萃分析。
Front Immunol. 2024 Sep 16;15:1459693. doi: 10.3389/fimmu.2024.1459693. eCollection 2024.
3
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.对局部晚期宫颈癌女性患者进行子宫切除术并辅以放疗或化疗或两者联合治疗。
Cochrane Database Syst Rev. 2015 Apr 7(4):CD010260. doi: 10.1002/14651858.CD010260.pub2.
4
Corrigendum: Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic review.勘误：食管癌中免疫检查点抑制剂与胸部放疗联合应用的毒性特征：一项荟萃分析和系统评价。
Front Immunol. 2023 Apr 11;14:1193710. doi: 10.3389/fimmu.2023.1193710. eCollection 2023.
5
Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial.特瑞普利单抗联合含铂化疗同期放疗治疗局部晚期宫颈癌患者的开放标签、单臂、Ⅱ期临床试验。
BMC Cancer. 2022 Jul 19;22(1):793. doi: 10.1186/s12885-022-09866-w.
6
Corrigendum: Total neoadjuvant therapy based on short-course radiotherapy versus standard long-course chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis of randomized controlled trials.勘误：基于短程放疗与标准长程放化疗的全新辅助治疗用于局部晚期直肠癌：一项随机对照试验的系统评价和荟萃分析
Front Oncol. 2025 Jan 14;14:1552188. doi: 10.3389/fonc.2024.1552188. eCollection 2024.
7
Efficacy and safety of PD-1 inhibitor combined with concurrent chemoradiotherapy in locally advanced cervical cancer with pelvic and/or para-aortic lymph node metastases: a retrospective cohort study.PD-1 抑制剂联合同期放化疗治疗盆腔和/或腹主动脉旁淋巴结转移的局部晚期宫颈癌的疗效和安全性：一项回顾性队列研究。
Chin Clin Oncol. 2023 Aug;12(4):38. doi: 10.21037/cco-23-70.
8
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.根治性子宫切除术联合放化疗与单纯根治性子宫切除术治疗局部晚期宫颈癌的疗效比较
Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD010260. doi: 10.1002/14651858.CD010260.pub3.
9
Platinum single-agent vs. platinum-based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer: A meta-analysis of randomized controlled trials.铂类单药与铂类为基础的双药联合同期放化疗治疗局部晚期宫颈癌的比较：一项随机对照试验的荟萃分析。
Gynecol Oncol. 2019 Jul;154(1):246-252. doi: 10.1016/j.ygyno.2019.04.013. Epub 2019 Apr 18.
10
Efficacy and safety of endostar combined with chemoradiotherapy versus chemoradiotherapy alone in locally advanced cervical cancer: A PRISMA-compliant systematic review and meta-analysis.恩度联合放化疗对比单纯放化疗治疗局部晚期宫颈癌的有效性和安全性：一项基于 PRISMA 指南的系统评价和荟萃分析。
Medicine (Baltimore). 2022 Sep 9;101(36):e30170. doi: 10.1097/MD.0000000000030170.
Zotero 插件